Dr. Julia Sohn Featured in Everyday Health for COVID-19 Nasal Spray Prevention Study

Dr. Julia Sohn, board-certified allergist and immunologist with AllerVie Health, was recently featured in Everyday Health in coverage of a new clinical trial evaluating the potential of a common over-the-counter (OTC) allergy nasal spray to help prevent COVID-19 infection.

The article, titled “Common Nasal Spray May Help Prevent COVID-19, Study Suggests”, highlights early research that is prompting further investigation into the antiviral benefits of certain nasal sprays. As part of the feature, Dr. Sohn was invited to weigh in on the relevance of the study from an allergy and immunology perspective.

Dr. Sohn provided clinical context around nasal sprays’ mechanisms and their relevance to upper respiratory protection. Her input reflects AllerVie Health’s commitment to clinical excellence and our broader mission to advance the field of allergy and immunology through trusted, expert care.

With a strong foundation in both patient-centered practice and research, Dr. Sohn continues to represent the high caliber of care AllerVie providers bring to communities nationwide. Her participation in national media reflects our organization’s leadership in driving conversations around innovative approaches to health and wellness, especially those at the intersection of allergy treatment and infectious disease prevention.